Photo of Markella V. Zanni, MD

Markella V. Zanni, MD


Accepting New Patients





Clinical Interests
  • Pituitary tumors
  • Prolactinomas
Medical Education
  • MD, Harvard Medical School
  • Residency, Brigham and Women's Hospital
  • Fellowship, Massachusetts General Hospital
Board Certifications
  • Internal Medicine
  • Endocrinology
  • Diabetes & Metabolism
  • Boston: Massachusetts General Hospital
Patient Gateway
Yes, learn more
Insurances Accepted
  • Aetna Health Inc.
  • Beech Street
  • Blue Cross Blue Shield - Blue Care 65
  • Blue Cross Blue Shield - Indemnity
  • Blue Cross Blue Shield - Managed Care
  • Blue Cross Blue Shield - Partners Plus
  • Centene/Celticare
  • Cigna (PAL #'s)
  • Fallon Community HealthCare
  • Great-West Healthcare (formally One Health Plan)
  • Harvard Pilgrim Health Plan - ACD
  • Harvard Pilgrim Health Plan - PBO
  • Health Care Value Management (HCVM)
  • Humana/Choice Care PPO
  • Medicaid
  • Medicare
  • Medicare - ACD
  • Neighborhood Health Plan - ACD
  • Neighborhood Health Plan - PBO
  • OSW - Maine
  • OSW - New Hampshire
  • OSW - Rhode Island
  • Private Health Care Systems (PHCS)
  • Senior Whole Health
  • TriCare
  • Tufts Health Plan
  • Unicare
  • United Healthcare (non-HMO) - ACD
  • United Healthcare (non-HMO) - PBO
Patient Age Group

Edit Profile


Markella V. Zanni, MD, is a physician in the Massachusetts General Hospital Neuroendocrine Clinical Center (MGH NECC), a Faculty member in the Neuroendocrine Unit at MGH, and an Assistant Professor of Medicine at Harvard Medical School. She is a clinical researcher in the MGH Program in Nutritional Metabolism and she studies metabolic and cardiovascular complications of inflammation.

Edit Profile

Research & Publications

Research Summary
Dr. Zanni is a clinical researcher who studies metabolic and cardiovascular complications of inflammation. Specifically, her research interests include the role of systematic inflammation in mediating cardiovascular and metabolic compilation in a variety of disease states including obesity, HIV, and psoriasis. Dr. Zanni is also interested in the neuroendocrine regulation of obesity.

View my most recent publications at PubMed

Zanni MV*, Burdo TH*, Makimura H, Williams KC, Grinspoon SK. Relationship between Monocyte/Macrophage Activation Marker Soluble CD163 and Insulin Resistance in Obese and Normal-Weight Subjects. Clin Endocrinol. 2011 Nov 19. (PMID 22098563)  

Zanni MV*, Abbara SA*, Lo J, Wai B, Hark D, Marmarelis E, Grinspoon SK. "Increased Coronary Atherosclerotic Plaque Vulnerability by Coronary Computed Tomography Angiography in HIV-Infected Men." AIDS. 2013 May 15;27(8):1263-72. PMC3740057

Zanni MV*, Kelesidis* T, Fitzgerald ML, Lo J, Abbara S, Wai B, Marmarelis E, Hernandez NJ, Yang OO, Currier JS, Grinspoon SK. HDL redox activity is increased in HIV-infected men in association with macrophage activation and noncalcified coronary atherosclerotic plaque. Antivir Ther. 2014 Feb 17. Epub ahead of print. PMID 24535655. 

Edit Profile


Neuroendocrine Clinical Center
Zero Emerson Place
Suite 112
Boston MA, 02114-2217
Phone: 617-726-7948
Fax: 617-726-1241

Edit Profile

Back to Top